Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

Filters applied:

Cancelled under Section 30(1)(c) of the Act

Clear all

24849 result(s) found, displaying 5126 to 5150

GLYADE 60 mg MR gliclazide 60 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Servier Laboratories (Aust) Pty Ltd
GRANISETRON SANDOZ granisetron (as hydrochloride) 1mg/1mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Sandoz Pty Ltd
GRANISETRON SANDOZ granisetron (as hydrochloride) 3mg/3mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Sandoz Pty Ltd
Gut Maintain Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by PuraU
Gut Primer Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by The Beauty Chef Pty Ltd
Gut Repair Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by The Way Up Nutrition
HELP IT ULTRA SPF50+ SUNSCREEN LOTION Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Ensign Laboratories Pty Ltd
ImmunoSTART Tablets Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Mannatech Australia Pty Ltd
Imunor Kids Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Zifam Pinnacle Pty Ltd
IQ Plus Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Contract Manufacturing & Packaging Services Pty Ltd
IRBESARTAN ACTAVIS 150 irbesartan 150 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRBESARTAN ACTAVIS 300 irbesartan 300 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRBESARTAN ACTAVIS 75 irbesartan 75 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRBESTIN irbesartan 150mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRBESTIN irbesartan 300mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRBESTIN irbesartan 75mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRBETAN irbesartan 150mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRBETAN irbesartan 300mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRBETAN irbesartan 75mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRINOTECAN ACT irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRINOTESIN 100mg/5mL irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRINOTESIN 40mg/2mL irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRINOTESIN 500mg/25mL irinotecan hydrochloride trihydrate 500mg/25mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
K2Q Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Contract Manufacturing & Packaging Services Pty Ltd
KARVATAN irbesartan 150mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

GLYADE 60 mg MR gliclazide 60 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

GRANISETRON SANDOZ granisetron (as hydrochloride) 1mg/1mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

GRANISETRON SANDOZ granisetron (as hydrochloride) 3mg/3mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

Gut Maintain Cancelled under Section 30(1)(c) of the Act

Gut Primer Cancelled under Section 30(1)(c) of the Act

Gut Repair Cancelled under Section 30(1)(c) of the Act

HELP IT ULTRA SPF50+ SUNSCREEN LOTION Cancelled under Section 30(1)(c) of the Act

ImmunoSTART Tablets Cancelled under Section 30(1)(c) of the Act

Imunor Kids Cancelled under Section 30(1)(c) of the Act

IQ Plus Cancelled under Section 30(1)(c) of the Act

IRBESARTAN ACTAVIS 150 irbesartan 150 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

IRBESARTAN ACTAVIS 300 irbesartan 300 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

IRBESARTAN ACTAVIS 75 irbesartan 75 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

IRBESTIN irbesartan 150mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

IRBESTIN irbesartan 300mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

IRBESTIN irbesartan 75mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

IRBETAN irbesartan 150mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

IRBETAN irbesartan 300mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

IRBETAN irbesartan 75mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

IRINOTECAN ACT irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

IRINOTESIN 100mg/5mL irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

IRINOTESIN 40mg/2mL irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

IRINOTESIN 500mg/25mL irinotecan hydrochloride trihydrate 500mg/25mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

K2Q Cancelled under Section 30(1)(c) of the Act

KARVATAN irbesartan 150mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

Is there anything wrong with this page?